The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
StockStory.org on MSN
A look back at drug development inputs & services stocks’ Q4 earnings: Charles River Laboratories (NYSE:CRL) vs the rest of the pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
IQVIA Holdings (NYSE:IQV) has agreed to acquire discovery services assets from Charles River Laboratories. The deal adds in vitro discovery capabilities across five additional sites to IQVIA's ...
IAccess Alpha Virtual Best Ideas Spring Investment Conference 2026 March 10, 2026 2:00 PM EDTCompany ParticipantsMichael Feldschuh ...
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...
Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.
A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.
From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...
Drug discovery is like molecular Tetris. Chemists snap atoms together, adjusting the pieces until everything fits, and ...
The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results